Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil Gross

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Head & Neck|December 16, 2022
Clinical outcomes of combined cervical and transthoracic surgical approaches in patients with advanced thyroid cancerJared A Shenson, Mark E Zafereo, Mark Lee, et al.
Nature Cancer|January 2, 2026
Intratumoral bacteria are immunosuppressive and promote immunotherapy resistance in head and neck squamous cell carcinomaNatalie L Silver, Jin Dai, Travis D Kerr, et al.
American Journal of Epidemiology|November 30, 2019
Risk Prediction Models for Head and Neck Cancer in the US Population From the INHANCE ConsortiumYuan-Chin Amy Lee, Mohammed Al-Temimi, Jian Ying, et al.
International Journal of Cancer|April 21, 2026
Risk of Head and Neck Cancer in Former Smokers by Subsite: A Multicenter Analysis From the INHANCE ConsortiumMatheus de Abreu, Luiz Paulo Kowalski, Rossana Mendoza López, et al.
Nature Medicine|October 27, 2018
Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanomaRodabe N Amaria, Sangeetha M Reddy, Hussein A Tawbi, et al.
Nature Medicine|October 10, 2018
Neoadjuvant immune checkpoint blockade in high-risk resectable melanomaRodabe N Amaria, Sangeetha M Reddy, Hussein A Tawbi, et al.
Nature Medicine|October 27, 2018
Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanomaRodabe N Amaria, Sangeetha M Reddy, Hussein A Tawbi, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Head & Neck|December 16, 2022
Clinical outcomes of combined cervical and transthoracic surgical approaches in patients with advanced thyroid cancerJared A Shenson, Mark E Zafereo, Mark Lee, et al.
Nature Cancer|January 2, 2026
Intratumoral bacteria are immunosuppressive and promote immunotherapy resistance in head and neck squamous cell carcinomaNatalie L Silver, Jin Dai, Travis D Kerr, et al.
American Journal of Epidemiology|November 30, 2019
Risk Prediction Models for Head and Neck Cancer in the US Population From the INHANCE ConsortiumYuan-Chin Amy Lee, Mohammed Al-Temimi, Jian Ying, et al.
International Journal of Cancer|April 21, 2026
Risk of Head and Neck Cancer in Former Smokers by Subsite: A Multicenter Analysis From the INHANCE ConsortiumMatheus de Abreu, Luiz Paulo Kowalski, Rossana Mendoza López, et al.
Nature Medicine|October 27, 2018
Author Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanomaRodabe N Amaria, Sangeetha M Reddy, Hussein A Tawbi, et al.
Nature Medicine|October 10, 2018
Neoadjuvant immune checkpoint blockade in high-risk resectable melanomaRodabe N Amaria, Sangeetha M Reddy, Hussein A Tawbi, et al.
Nature Medicine|October 27, 2018
Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanomaRodabe N Amaria, Sangeetha M Reddy, Hussein A Tawbi, et al.
Pageof 6